Analgesia Nociception Index Guided Remifentanil Administration During Propofol Anesthesia for Laparoscopic Surgery

NCT ID: NCT01893723

Last Updated: 2015-11-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

37 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-06-30

Study Completion Date

2015-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The Physiodoloris (MetroDoloris, Lille, France) monitor, CE marqued, uses the ECG signal in order to compute the Analgesia Nociception Index (ANI) which has been shown to measure the relative parasympathetic tone, and hence to reflect the analgesia/nociception balance during general anesthesia. The primary endpoint of this randomized multicenter study is to measure whether there is a benefit to use the ANI in order to adapt remifentanil administration during propofol anesthesia for laparoscopic surgery. Primary endpoint : lesser proportion of patients presenting with at least one episode of hemodynamic reactivity, hypotension or bradycardia in the ANI guided group vs control group ?

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Physiodoloris (MetroDoloris, Lille, France) monitor, CE marqued, uses the ECG signal in order to compute the Analgesia Nociception Index (ANI) which has been shown to measure the relative parasympathetic tone, and hence to reflect the analgesia/nociception balance during general anesthesia. The primary endpoint of this randomized multicenter study is to measure whether there is a benefit to use the ANI in order to adapt remifentanil administration during propofol anesthesia for laparoscopic surgery. Primary endpoint is: lesser proportion of patients presenting with at least one episode of hemodynamic reactivity, hypotension or bradycardia in the ANI guided group vs control group ?

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

General Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ANI guided remifentanil arm

remifentanil targets are increased or decreased depending on ANI readings. In case of high blood pressure associated with elevated ANI, nicardipine is administered.

Group Type EXPERIMENTAL

ANI guided remifentanil

Intervention Type PROCEDURE

remifentanil administration during propofol anesthesia for laparoscopic surgery is ANI guided

ANI blind arm

remifentanil target is adapted as is usual during general anesthesia, depending on hemodynamic reactions to nociceptive surgical stimulations. In case of elevated blood pressure despite a maximum target of 10 ng/ml (Minto Pk/pD model), then nicardipine is administered.

Group Type OTHER

ANI blind arm

Intervention Type PROCEDURE

remifentanil administration during propofol anesthesia for laparoscopic surgery is not ANI guided

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ANI guided remifentanil

remifentanil administration during propofol anesthesia for laparoscopic surgery is ANI guided

Intervention Type PROCEDURE

ANI blind arm

remifentanil administration during propofol anesthesia for laparoscopic surgery is not ANI guided

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* laparoscopic cholecystectomy or gynecological laparoscopic surgery
* ASA I or II
* adult patient
* body mass index between 17 and 33 kg/m2

Exclusion Criteria

* pregnancy
* arrhythmia
* pace maker
* diabetes mellitus
* dysautonomia
* treatment with beta blocking agents
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Lille

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mathieu JEANNE, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Lille

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Erasme (ULB)

Brussels, , Belgium

Site Status

Clinique privée d'ANTONY

Antony, , France

Site Status

University Hospital Claude Huriez

Lille, , France

Site Status

University Hospital Roger Salengro

Lille, , France

Site Status

University Hospital

Saint-Etienne, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-A00947-34

Identifier Type: OTHER

Identifier Source: secondary_id

2010_51

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.